Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × NETWORK × Daunorubicin × Clear all

Phase

Status

Completed 33 Active not recruiting 3 Withdrawn 2 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

OTHER 3 INDUSTRY 2 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 5 Magnetic Resonance Spectroscopy 4 Standard of Care 3 Practice Guidelines as Topic 3 Cyclophosphamide 3 Biopsy 3 Radiotherapy 2 Cytarabine 2 zanubrutinib 1 venetoclax 1 talquetamab 1 sulforaphane 1 sacituzumab govitecan 1 liposomal doxorubicin 1 fludarabine 1 daratumumab 1 asciminib 1 X-Rays 1 Vinorelbine 1 Vincristine 1 Stem Cell Transplantation 1 Spinal Puncture 1 Sentinel Lymph Node Biopsy 1 Radiation 1 Propranolol 1 Pluvicto 1 Pharmaceutical Preparations 1 Paclitaxel 1 Methods 1 Lidocaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05628623 2024-07-03

ERASE

Eastern Cooperative Oncology Group

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡